These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17957141)

  • 1. Stimulus-specific transcriptional regulation within the p53 network.
    Donner AJ; Hoover JM; Szostek SA; Espinosa JM
    Cell Cycle; 2007 Nov; 6(21):2594-8. PubMed ID: 17957141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK8 is a stimulus-specific positive coregulator of p53 target genes.
    Donner AJ; Szostek S; Hoover JM; Espinosa JM
    Mol Cell; 2007 Jul; 27(1):121-33. PubMed ID: 17612495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
    Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.
    Gomes NP; Espinosa JM
    Cell Cycle; 2010 Sep; 9(17):3428-37. PubMed ID: 20818159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
    Espinosa JM; Emerson BM
    Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
    Kan CE; Patton JT; Stark GR; Jackson MW
    Cancer Res; 2007 Oct; 67(20):9862-8. PubMed ID: 17942917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
    Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
    Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells.
    Menendez D; Nguyen TA; Freudenberg JM; Mathew VJ; Anderson CW; Jothi R; Resnick MA
    Nucleic Acids Res; 2013 Aug; 41(15):7286-301. PubMed ID: 23775793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation.
    Xia M; Knezevic D; Vassilev LT
    Oncogene; 2011 Jan; 30(3):346-55. PubMed ID: 20871630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM; Nugent JK; Zhao X; Irwin MS
    Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation.
    París R; Henry RE; Stephens SJ; McBryde M; Espinosa JM
    Cell Cycle; 2008 Aug; 7(15):2427-33. PubMed ID: 18677110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress.
    Chang J; Davis-Dusenbery BN; Kashima R; Jiang X; Marathe N; Sessa R; Louie J; Gu W; Lagna G; Hata A
    EMBO J; 2013 Dec; 32(24):3192-205. PubMed ID: 24219989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
    Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
    EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
    Kumamoto K; Spillare EA; Fujita K; Horikawa I; Yamashita T; Appella E; Nagashima M; Takenoshita S; Yokota J; Harris CC
    Cancer Res; 2008 May; 68(9):3193-203. PubMed ID: 18451145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
    Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
    Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.